Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
22.18
-1.90 (-7.89%)
Aug 21, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 10.6 billion as of August 21, 2026. Its market cap has decreased by -59.79% in one year.
Market Cap
10.60B
Enterprise Value
10.57B
Revenue
203.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.18
ChartMarket Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 10.60B, an increase of 218.49%. That is a compound annual growth rate of 7.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 10.60B | -18.81% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.47B |
| Nanjing Vazyme Biotech | 11.97B |
| Chengdu Olymvax Biopharmaceuticals | 11.65B |
| Inner Mongolia Furui Medical Science | 11.59B |
| Tibet Cheezheng Tibetan Medicine | 11.53B |
| Chengzhi | 11.36B |
| Hualan Biological Vaccine | 10.61B |
| Vcanbio Cell & Gene Engineering Corp., | 10.23B |